PE Hub Wire

Optimism for take-private deals after Sycamore’s move for Walgreens Boots Alliance; Steady stream of food-service deals continue in 2025

Michael Blankenship, co-chair of Winston & Strawn’s capital markets practice and Houston managing partner, on take-private deals in private equity this year; the subsector of food-service and why it’s attractive to PE firms; Bain Capital's deal for HealthEdge, a Burlington, Massachusetts-based healthcare tech company.

SVP, Blantyre buy global chemicals biz; EQT nears exit of E45 moisturizer producer Karo to KKR, say sources; KKR, Stonepeak bid wins Assura board backing

OQ Chemicals is a global producer and merchant of oxo chemicals.

Private equity taps into Europe’s diversified approach to energy; LDC’s RDi completes add-on

LDC portfolio company RDi has completed the acquisition of Inicio Health, a UK-based clinically led healthcare company.

Hamilton Lane’s Erik Hirsch: 'private markets, particularly private equity, outperform by the greatest amount' in down periods; what’s your take?

How are the tariffs affecting dealmaking in the sectors you invest in? How are they affecting deals already in the works? How are they affecting your portfolio companies? What strategies are you deploying to handle them? What targets have become less attractive, what targets have become more attractive?